Insider for company (NASDAQ: SOPH) plans sale of 30,000 shares
Rhea-AI Filing Summary
Form 144 for SOPH reports a proposed sale of 30,000 shares of common stock with an aggregate market value of $144,000.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 01/07/2026, and the stock is listed on NASDAQ, where 67,847,058 common shares are shown as outstanding.
The securities to be sold include 17,933 common shares acquired on 01/07/2026 via exercise of stock options for cash and 12,067 founder shares acquired on 03/18/2021. The filing also lists prior Rule 10b5-1 sales for JURGI CAMBLONG over the past three months, such as 16,948 common shares sold on 01/06/2026 for gross proceeds of
Positive
- None.
Negative
- None.
FAQ
What does SOPH's Form 144 filing disclose?
The Form 144 notice discloses a proposed sale of 30,000 shares of SOPH common stock with an aggregate market value of
How many SOPH shares are planned to be sold under this Form 144?
The filing indicates an intention to sell 30,000 shares of common stock, with an aggregate market value listed as
How were the SOPH shares in this Form 144 acquired?
The securities to be sold include 17,933 common shares acquired on 01/07/2026 through an exercise of stock options paid in cash, and 12,067 founder shares acquired on 03/18/2021 from the issuer.
What is the total number of SOPH shares outstanding mentioned in the Form 144?
The Form 144 lists 67,847,058 common shares as outstanding for SOPH in connection with the proposed sale information.
Which broker and exchange are involved in the SOPH Form 144 sale?
The proposed sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are listed for trading on the NASDAQ exchange.
What recent Rule 10b5-1 sales related to SOPH are listed in the Form 144?
The filing lists multiple Rule 10b5-1 sales for JURGI CAMBLONG over the past three months, including 16,948 common shares sold on 01/06/2026 for gross proceeds of